Marshall Wace North America L.P. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 783 filers reported holding GLAXOSMITHKLINE PLC in Q2 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q3 2020$13,082,000
+614.1%
347,554
+709.1%
0.08%
+740.0%
Q3 2019$1,832,000
+1377.4%
42,953
+1331.8%
0.01%
Q1 2019$124,000
-94.3%
3,000
-94.4%
0.00%
-100.0%
Q2 2018$2,159,000
-89.4%
53,577
-89.7%
0.01%
-88.2%
Q1 2018$20,344,000
-76.4%
520,703
-78.6%
0.10%
-78.6%
Q4 2017$86,165,000
+7.6%
2,429,235
+24.4%
0.48%
-6.1%
Q3 2017$80,064,000
+66.3%
1,952,779
+74.4%
0.51%
+44.0%
Q2 2017$48,138,000
+153.9%
1,119,491
+148.0%
0.35%
+134.7%
Q1 2017$18,959,000451,4030.15%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q2 2017
NameSharesValueWeighting ↓
KAHN BROTHERS GROUP INC 1,282,289$46,483,4037.25%
Columbia Asset Management 9,960$3610.08%
PARK CIRCLE Co 800$29,0000.03%
PARADIGM ASSET MANAGEMENT CO LLC 1,800$65,2500.02%
Byrne Asset Management LLC 56$2,0000.00%
Retirement Group, LLC 40$1,4500.00%
Bartlett & Co. LLC 240$90.00%
HUNTINGTON NATIONAL BANK 1$400.00%
View complete list of GLAXOSMITHKLINE PLC shareholders